Vigdis Nygaard
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Molecular Biology Techniques and Applications
- Gene expression and cancer classification
- Melanoma and MAPK Pathways
- RNA Research and Splicing
- Single-cell and spatial transcriptomics
Papers in
-
- Molecular Biology Techniques and Applications 6
- Gene expression and cancer classification 6
- Single-cell and spatial transcriptomics 3
- Melanoma and MAPK Pathways 3
- S100 Proteins and Annexins 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Eivind Hovig (8 shared papers)Lina Prasmickaite (4 shared papers)Ola Myklebost (4 shared papers)Gunhild M. Mælandsmo (9 shared papers)Anders Løland (2 shared papers)Mette Langaas (2 shared papers)Marit Holden (3 shared papers)Trevor Clancy (2 shared papers)
- Journals
- BMC Genomics (3 papers)Cancer Letters (2 papers)Oncotarget (2 papers)Molecular Cancer Therapeutics (1 paper)Translational Oncology (1 paper)
- Partner nations
- NorwayUnited StatesNetherlands
In The Last Decade
Vigdis Nygaard
18 papers receiving 494 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 101
- Molecular Biology 342
- Oncology 98
- Immunology 70
- Genetics 32
Countries citing papers authored by Vigdis Nygaard
This map shows the geographic impact of Vigdis Nygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vigdis Nygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vigdis Nygaard more than expected).
Fields of papers citing papers by Vigdis Nygaard
This network shows the impact of papers produced by Vigdis Nygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vigdis Nygaard. The network helps show where Vigdis Nygaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Vigdis Nygaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 103 | |
| 2 | 2015 | 67 | |
| 3 | 2003 | 63 | |
| 4 | 2004 | 42 | |
| 5 | 2013 | 42 | |
| 6 | 2014 | 35 | |
| 7 | 2005 | 32 | |
| 8 | 2017 | 25 | |
| 9 | 2016 | 25 | |
| 10 | 2002 | 25 | |
| 11 | 2009 | 19 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 5 | |
| 14 | 2021 | 4 | |
| 15 | Samiske interessers legitimitet og status i politiske og forvaltningsmessige plan- og beslutningsprosesser | 2017 | 3 |
| 16 | 2023 | 3 | |
| 17 | Kartlegging av samisk perspektiv i kommunesektoren | 2012 | 3 |
| 18 | 2008 | 2 | |
| 19 | 2018 | 0 |
About Vigdis Nygaard
Vigdis Nygaard is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Political Science and International Relations and Pathology and Forensic Medicine, having authored 19 papers that have together received 508 indexed citations. Recurring topics across this work include Molecular Biology Techniques and Applications (6 papers), Gene expression and cancer classification (6 papers), Single-cell and spatial transcriptomics (3 papers), Melanoma and MAPK Pathways (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and S100 Proteins and Annexins (2 papers). The work is most often cited by research in Cancer Research (101 citations), Molecular Biology (342 citations), Oncology (98 citations), Immunology (70 citations) and Genetics (32 citations). Vigdis Nygaard has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Eivind Hovig, Lina Prasmickaite, Ola Myklebost, Gunhild M. Mælandsmo, Anders Løland, Mette Langaas, Marit Holden, Trevor Clancy, Birgitte Smith‐Sørensen and Solveig Pettersen. Their work appears in journals such as BMC Genomics, Cancer Letters, Oncotarget, Molecular Cancer Therapeutics and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.